Longitudinal Changes of Right Ventricular Deformation Mechanics During Trastuzumab Therapy in Breast Cancer Patients
Kalliopi Keramida(National and Kapodistrian University of Athens), Petros Nihoyannopoulos, Nikolaos Kouris(Thriasio General Hospital of Elefsina), Chara Tzavara(Athens State University), Kanchana Ramachandran(West Hertfordshire Hospitals NHS Trust), Dimitrios Farmakis, Samir Sulemane(Imperial College Healthcare NHS Trust), Jose Bingcang(Barts Health NHS Trust), Dimitrios Filippiadis(National and Kapodistrian University of Athens), Stephanie Sutherland(West Hertfordshire Hospitals NHS Trust), Georgios Charalampopoulos(National and Kapodistrian University of Athens), Roma A. Bingcang(Barts Health NHS Trust)
Cited by 93
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|714